962369.fig.002a
(a)
962369.fig.002b
(b)
962369.fig.002c
(c)
962369.fig.002d
(d)
962369.fig.002e
(e)
Figure 2: Effect of rosuvastatin on leukocyte recruitment to the femoral artery of ApoE−/− mice. ApoE−/− mice were administered HF with rosuvastatin for 6 weeks of age to 6 weeks. (a) Captured image of leukocyte interaction in a femoral artery treated with vehicle (left) and rosuvastatin (right). The number of adherent leukocytes was quantified by image analysis software. (b) Effect of rosuvastatin on expression levels of VCAM-1 and ICAM-1 (* ). (c) Microphotographs of aortas in ApoE−/− mice treated with vehicle or rosuvastatin and stained by DHE (×200). (d) Effect of rosuvastatin on expression levels of gp91-phox and p22-phox in aortas of ApoE−/− mice (* ). (e) Total cholesterol level and triglyceride level in plasma of HF-fed ApoE−/− mice treated with vehicle or rosuvastatin.